Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  motexafin gadolinium
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Contrast-Enhanced CT Scan and Contrast-Enhanced MRI in Diagnosing and Staging Liver Cancer in Patients With Chronic Liver Disease
Phase: Phase III
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 18 and over
Trial IDs: ACRIN 6690, NCI-2011-02020, CA80098, CDR0000667125, NCT01082224
Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: N1174, NCI-2012-01989, CDR0000737109, NCCTG-N1174, NCT01648348
Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors before or after Treatment in Patients with Primary or Metastatic Brain Tumors
Phase: Phase II
Type: Diagnostic
Age: 18 to 75
Trial IDs: 2864, NCI-2015-00225, SOL-06077-L, NCT00659126
18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients with Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase I
Type: Diagnostic
Age: 18 and over
Trial IDs: 2014-0616, NCI-2015-00525, NCT02390635
DSC-MRI with Ferumoxytol and DCE-MRI with Gadolinium in Imaging Vascular Properties in Younger Patients with Brain Tumors
Phase: No phase specified
Type: Diagnostic
Age: 18 and under
Trial IDs: 5405, NCI-2015-00227, 1562, 2864, 813, SOL-09064-LX, NCT00978562
Studying Repeated Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging in Patients Diagnosed With Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: ACRIN 6701, NCI-2012-00711, CA80098, CDR0000728901, NCT01562223
Start Over